GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.820
-0.140 (-7.14%)
At close: Jun 26, 2026, 4:00 PM EDT
1.880
+0.060 (3.30%)
After-hours: Jun 26, 2026, 7:51 PM EDT
GRI Bio Stock Forecast
GRI's stock price has decreased by -95.19% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for GRI Bio stock have an average target of 21, with a low estimate of 10 and a high estimate of 32. The average target predicts an increase of 1,053.85% from the current stock price of 1.82.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for GRI Bio stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Nov '25 | Dec '25 | Mar '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant | Ascendiant | Buy Maintains $40 → $32 | Buy | Maintains | $40 → $32 | +1,658.24% | May 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $10 | Buy | Reiterates | $10 | +449.45% | May 14, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.77
from -121.80
EPS Next Year
-2.54
from -4.77
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -4.41 | -0.26 | |
| Avg | -4.77 | -2.54 | |
| Low | -5.13 | -4.81 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.